Dr. Claire McLintock visited ISTH Congress Daily News to mark the 50th anniversary of the ISTH and to share some of her most memorable experiences at the congress over the years. She described the impact the society has had on advancements in science and clinical outcomes for patients with thrombosis and hemostasis, most notably the exciting potential of new therapies, such as gene therapy in hemophilia and advancements in the treatment of thrombosis without the risk of bleeding. Dr. McLintock describes the many benefits of joining ISTH, and how members can take a more active role in this growing community of researchers and clinicians.

Share this story, choose your platform!